BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27788733)

  • 1. [Fine particulate matter and nonalcoholic fatty liver disease].
    Li M; Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):713-715. PubMed ID: 27788733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged PM2.5 exposure elevates risk of oxidative stress-driven nonalcoholic fatty liver disease by triggering increase of dyslipidemia.
    Xu MX; Ge CX; Qin YT; Gu TT; Lou DS; Li Q; Hu LF; Feng J; Huang P; Tan J
    Free Radic Biol Med; 2019 Jan; 130():542-556. PubMed ID: 30465824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of PM
    Chen J; Wu L; Yang G; Zhang C; Liu X; Sun X; Chen X; Wang N
    Life Sci; 2021 Apr; 270():119135. PubMed ID: 33513397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to ambient air particulate matter and non-alcoholic fatty liver disease.
    Tarantino G; Capone D; Finelli C
    World J Gastroenterol; 2013 Jul; 19(25):3951-6. PubMed ID: 23840139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome.
    Lim S; Taskinen MR; Borén J
    Obes Rev; 2019 Apr; 20(4):599-611. PubMed ID: 30589487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine Particulate Matter and Emergency Room Visits for Respiratory Illness. Effect Modification by Oxidative Potential.
    Weichenthal SA; Lavigne E; Evans GJ; Godri Pollitt KJ; Burnett RT
    Am J Respir Crit Care Med; 2016 Sep; 194(5):577-86. PubMed ID: 26963193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications.
    Miele L; Targher G
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1243-5. PubMed ID: 26224399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis.
    Xu X; Lu L; Dong Q; Li X; Zhang N; Xin Y; Xuan S
    Lipids Health Dis; 2015 Dec; 14():158. PubMed ID: 26631018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic aspects of adult patients with nonalcoholic fatty liver disease.
    Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A
    World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between fine particulate air pollution, cardiometabolic disorders, and cardiovascular mortality.
    Pope CA; Turner MC; Burnett RT; Jerrett M; Gapstur SM; Diver WR; Krewski D; Brook RD
    Circ Res; 2015 Jan; 116(1):108-15. PubMed ID: 25348167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter.
    Chiriac S; Stanciu C; Girleanu I; Cojocariu C; Sfarti C; Singeap AM; Cuciureanu T; Huiban L; Muzica CM; Zenovia S; Nastasa R; Trifan A
    Can J Gastroenterol Hepatol; 2021; 2021():6696857. PubMed ID: 33505944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders.
    Lim S; Oh TJ; Koh KK
    Int J Cardiol; 2015 Dec; 201():408-14. PubMed ID: 26310987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term exposure to air pollution, habitual physical activity and risk of non-alcoholic fatty liver disease: A prospective cohort study.
    Sun S; Yang Q; Zhou Q; Cao W; Yu S; Zhan S; Sun F
    Ecotoxicol Environ Saf; 2022 Apr; 235():113440. PubMed ID: 35344898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver.
    Takamura T; Misu H; Ota T; Kaneko S
    Endocr J; 2012; 59(9):745-63. PubMed ID: 22893453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe.
    Simon TG; Corey KE; Chung RT; Giugliano R
    Dig Dis Sci; 2016 Dec; 61(12):3425-3435. PubMed ID: 27714510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms of air pollution and particulate matter in cardiovascular diseases.
    Fiordelisi A; Piscitelli P; Trimarco B; Coscioni E; Iaccarino G; Sorriento D
    Heart Fail Rev; 2017 May; 22(3):337-347. PubMed ID: 28303426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traffic-related air pollution is associated with cardio-metabolic biomarkers in general residents.
    Jiang S; Bo L; Gong C; Du X; Kan H; Xie Y; Song W; Zhao J
    Int Arch Occup Environ Health; 2016 Aug; 89(6):911-21. PubMed ID: 27084335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.